Vimarsana
Biggest News Aggregation in the World

Page 2 - General Internal News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from General Internal. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In General Internal Today - Breaking & Trending Today

Antibiotics Not Helpful for Cough Due to Lower Respiratory Tract Infection - Vimarsana News

Antibiotics Not Helpful for Cough Due to Lower Respiratory Tract Infection

Despite patient beliefs, no impact seen on severity, duration of cough.

Source: empr.com
Antibiotics Not Helpful for Cough Due to Lower Respiratory Tract Infection - Vimarsana News

Antibiotics Not Helpful for Cough Due to Lower Respiratory Tract Infection

Researchers reported that 29% of presenting patients had an antibiotic prescribed at baseline, most commonly amoxicillin-clavulanate, azithromycin, doxycycline, and amoxicillin.

Will free medical school diversify physician workforce? - Vimarsana News

Will free medical school diversify physician workforce?

A slew of medical colleges have gone tuition-free in recent years. But experts say it’s not enough to increase racial and ethnic diversity in the medical field. When the Einstein College of Medicine announced in February that a former faculty member donated a historic $1 billion to the institution to eliminate tuition for every student, leaders at the New York medical school lauded the gift’s potential to help diversify the physician workforce.

Forbes Daily: What's Next For TikTok? House Moves On Potential Ban - Vimarsana News

Forbes Daily: What's Next For TikTok? House Moves On Potential Ban

Monday’s edition of Forbes Daily covers the foreign aid and national security packages approved by the House, and how Boeing’s woes could impact air travel more broadly.

Source: forbes.com
New Diabetes Guidelines For Ozempic And Other GLP-1 Use - Vimarsana News

New Diabetes Guidelines For Ozempic And Other GLP-1 Use

The body for the first time is calling for GLP-1s as a treatment for Type 2 diabetes, but the medications are in short supply.

Source: forbes.com